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Subversion of the host immune system by viruses is often mediated by molecular decoys that
sequester host proteins pivotal to mounting effective immune responses. The widespread
mammalian pathogen parapox Orf virus deploys GIF, a member of the poxvirus immune
evasion superfamily, to antagonize GM-CSF (granulocyte macrophage colony-stimulating
factor) and IL-2 (interleukin-2), two pleiotropic cytokines of the mammalian immune system.
However, structural and mechanistic insights into the unprecedented functional duality of GIF
have remained elusive. Here we reveal that GIF employs a dimeric binding platform that
sequesters two copies of its target cytokines with high afﬁnity and slow dissociation kinetics
to yield distinct complexes featuring mutually exclusive interaction footprints. We illustrate
how GIF serves as a competitive decoy receptor by leveraging binding hotspots underlying
the cognate receptor interactions of GM-CSF and IL-2, without sharing any structural simi-
larity with the cytokine receptors. Our ﬁndings contribute to the tracing of novel molecular
mimicry mechanisms employed by pathogenic viruses.
DOI: 10.1038/ncomms13228 OPEN
1 Laboratory for Protein Biochemistry and Biomolecular Engineering, Department of Biochemistry and Microbiology, Ghent University, Technologiepark 927,
9052 Ghent, Belgium. 2 VIB Inﬂammation Research Center, Technologiepark 927, 9052 Ghent, Belgium. 3 University Grenoble Alpes, CNRS, CEA, IBS,
F-38044 Grenoble, France. 4 Bijvoet Center for Biomolecular Research, Faculty of Science, Utrecht University, 3584CH Utrecht, The Netherlands.
5 VIB Structural Biology Research Center, Vrije Universiteit Brussel, Pleinlaan 2, 1040 Brussels, Belgium. 6Masaryk University & CEITEC, 62500 Brno,
Czech Republic. 7 Department of Haematology, University of Cambridge School of Clinical Medicine, Cambridge Institute for Medical Research, Wellcome
Trust/MRC Building, Cambridge Biomedical Campus Box 139, Cambridge CB2 0XY, UK. Correspondence and requests for materials should be addressed to
S.N.S. (email: savvas.savvides@ugent.be).
NATURE COMMUNICATIONS | 7:13228 | DOI: 10.1038/ncomms13228 | www.nature.com/naturecommunications 1
T
hroughout evolution, mammalian viruses co-evolved with
their hosts and developed numerous immunomodulatory
strategies aimed at countering and evading antiviral
responses by the host immune system. Among the many different
immune evasion tactics deployed by viruses, are the use of
antigenic variation, latency, interference with antigen presenta-
tion, inhibition of apoptosis of viral infected cells and viral
mimicry1,2. The latter is mainly deployed by large DNA viruses of
the pox and herpes family, which encode viral homologues of
host cytokines, chemokines and their cognate receptors as
primary molecular detractors of the host immune response3–5.
The orf virus, a 140 kb double-stranded DNA (dsDNA) virus
from the parapoxfamily infects ruminants and humans world-
wide causing contagious ecthyma, also known as orf, a highly
spreadable skin condition characterized by severe lesions and
ulcerations6–9. As such, the socioeconomic footprint of orf is
estimated to be very large placing orf in the top 20 of the most
impactful diseases in developing countries or poor communities
with a heavy economic dependence on animal farming and
agrarian activities10,11. Infection by the Orf virus through
damaged skin elicits a severe and acute immune response
characterized by local accumulation of T cells, B cells, dermal
dendritic cells and neutrophils12,13. Although the Orf virus does
not inﬂict systemic infections and orf is generally not fatal, it can
lead to high mortality rates in young animals and children when
ulcerations prohibit food intake or can drastically affect ovine
ﬂock sizes when lesions would hinder reproduction8,14.
The Orf virus subverts the immune response by secreting
virulence proteins that inhibit or mimic key anti-inﬂammatory
host effector molecules15, including a chemokine-binding protein
(CKBP)16, an Orf virus homologue of interleukin-10 (orfIL-10)17
and vascular endothelial growth factor (VEGF-E)18, an interferon
resistance protein (OVIFNR) resembling the vaccinia virus E3L
gene19 and a secreted dual inhibitor of both granulocyte macro-
phage colony-stimulating factor (GM-CSF) and interleukin-2
(IL-2), termed GM-CSF/IL-2 inhibition factor (GIF)20.
The latter, GIF, is arguably one of the most intriguing viral
proteins known because it targets two distinct host proteins
pivotal to the host’s ability to mount an effective immune
response. For instance, GM-CSF is involved in the survival and
activation of macrophages, neutrophils and eosinophils, the
maturation of dendritic cells and differentiation of invariant
natural killer T cells21, while IL-2 is crucial for the maintenance of
regulatory T cells, and the proliferation of B cells, memory T cells
and NK cells22,23. GIF is distantly related to type-II CKBP
(CKBP-II), also known as the ‘vCCI’ or ‘orthopox 35kDa major
secreted virus’ family24–26, and displays restrictive cross-species
speciﬁcity since it is able to bind ovine GM-CSF and IL-2, but not
their human or murine orthologues20. However, the structural
and mechanistic basis for the remarkable functional duality
displayed by GIF has remained uncharacterized.
In this study, we employ an integrative structural biology
approach in an effort to elucidate the structural and mechanistic
principles of how a single viral protein can sequester two different
host proteins. Via a series of cross-validated structural snapshots
including the crystal structure of GIF in complex with GM-CSF,
two-dimensional (2D) classiﬁcations of GIF:GM-CSF and GIF:IL-2
complexes by negative-stain electron microscopy, the ensuing
three-dimensional (3D) reconstruction of the GIF:IL-2 complex,
and modeling of small-angle X-ray scattering (SAXS) data in
conjunction with multi-angle laser light scattering (MALLS)
measurements, we show that GIF adopts an obligate dimeric
structure that can bind two molecules of its target cytokines.
We further show via structure-based mutagenesis in combination
with interaction studies that GIF does so with high afﬁnity using a
mutually exclusive interaction site for both cytokines and plays
into binding principles utilized by the cognate receptors of
GM-CSF and IL-2. Together, our ﬁndings help to unmask the
molecular virtuosity gained during viral protein evolution
towards new protein ligand speciﬁcities and the molecular
mechanisms developed by viruses to subvert the host immune
response.
Results
Crystal structure of the GIF:GM-CSF complex. To obtain
structural insights at high resolution into the functional duality of
GIF as a cytokine-binding platform we sought to determine the
structure of GIF in complex with its target cytokines. Large-scale
production of recombinant GIF by transient expression in
HEK293T cells and subsequent puriﬁcation by immobilized-metal
afﬁnity chromatography (IMAC) and size-exclusion chromato-
graphy (SEC) initially led to prohibitory low amounts of puriﬁed
GIF protein and uncovered the tendency for recombinant GIF to
aggregate in standard puriﬁcation buffers. However, addition of a
molar excess of either recombinant ovine GM-CSF or IL-2 to
culture medium containing secreted recombinant GIF enabled
in situ reconstitution of GIF:GM-CSF and GIF:IL-2 complexes that
could be puriﬁed to homogeneity for further biophysical and
structural studies. Indeed, crystallization trials and subsequent
crystal optimization efforts yielded crystals of the GIF:GM-CSF
complex that enabled determination of the crystal structure to
2.8Å resolution (Table 1) allowing us to obtain for the ﬁrst time
structural snapshots of GIF and its complex with GM-CSF.
Our structural analyses reveal that GIF is an obligatory dimer,
consisting of two GIF subunits with an 11-strand b-sandwich
topology stabilized by three intramolecular disulﬁde bonds. Two
GIF protomers interact via b-strand complementation mediated
by strand bB and the C-terminal strand bK, resulting in an
extended and concave b-sandwich platform (Fig. 1a). The
ensuing dimeric GIF assembly is decorated by long loops and
two short a-helices at the ends of each GIF protomer, with a
dense cluster of N-linked glycans on the bottom side (Fig. 1a).
The GIF dimer interface is additionally stabilized by two sets of
interactions, one cluster centered around the intersheet disulﬁde
bridge between Cys59 on strand bB and Cys59 on bK on either
side of the twofold axis, and a second set mediated by the tips of
opposing G-H loops (Fig. 1b; Supplementary Table 1). Interest-
ingly, predictions of structural disorder identify the C-terminal 30
residues of GIF as intrinsically disordered. It is now clear that the
second half of that sequence is essential for constructing the
dimeric core structure of GIF, while the ﬁrst half in the JK loop
could not be modeled and might indeed be intrinsically
disordered. The b-sandwich core of GIF is very similar to the
fold representing poxviral CKBPs of the poxviral immune evasion
(PIE) superfamily (Fig. 2) consistent with prior predictions and
structural annotations27–31.
The GIF:GM-CSF complex features two molecules of GM-CSF
at equivalent interaction epitopes at the poles of the dimeric
b-sandwich platform (Fig. 1a). GM-CSF employs the helix-
bundle face deﬁned by helices aA and aD to interact with a rather
broad surface on GIF contributed by strands bF, bA, bI and bJ
burying B1,750Å2 of solvent-accessible surface area (Fig. 1c;
Supplementary Table 2). The interaction interface displays
striking electrostatic complementarity with GIF contributing a
highly basic surface ﬂanking an island of aromatic residues, while
GM-CSF projects a conspicuously acidic face of equal extent
(Fig. 1g; Supplementary Table 2). In contrast, the side of GIF not
involved in binding to GM-CSF displays opposite electrostatic
properties in that is highly acidic (Fig. 1g) and heavily
glycosylated (Fig. 1a).
Given the extensive interactions between GM-CSF and GIF,
we wondered whether GM-CSF undergoes any conformational
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changes upon binding to GIF. To enable such comparisons, we
determined the crystal structure of ovine GM-CSF (Table 1).
Structural superposition of the bound and unbound forms of
GM-CSF reveals that the helical bundle core of GM-CSF only
undergoes rather subtle main-chain and side-chain adjustments,
most notably Lys20 and Asn27 on helix aA, which tilt
downwards to interact with Gln41 and Trp43 on bA of GIF,
respectively (Supplementary Fig. 1). Furthermore, Glu108 on
helix aD reaches out to Arg106 on the E-F loop of GIF, whereas
Phe115 bends inwards to make place for His209 on bI of GIF.
We further note that in one of the two-bound GM-CSF
molecules, the N-terminal loop preceding helix aA at Gln14 is
disordered, whereas in the second copy of GM-CSF it swings
inwards by almost 180 to align roughly parallel to helix aA and
interact with Phe189 and Tyr228 on GIF (Supplementary Fig. 1;
Supplementary Table 2).
GIF–cytokine complexes are structurally distinct. Next we
sought to obtain comparative structural information on
GIF:GM-CSF and GIF:IL-2 complexes by negative-stain electron
microscopy (EM) using puriﬁed complexes following
co-expression of GIF with each of its target cytokines in
HEK293T cells (Fig. 3a,b; Supplementary Fig. 2). The ensuing 2D
class averages for the two complexes revealed particles with
apparent twofold symmetry, albeit with striking differences. On
one hand, the 2D class averages for the GIF:GM-CSF complex
(Fig. 3b) agreed very well with the crystal structure for the
GIF:GM-CSF complex (Fig. 1a). On the other hand, however, the
particle classiﬁcation for the GIF:IL-2 complex (Fig. 3a) showed a
drastically different assembly resembling a horseshoe-shaped
structure. This prompted us to proceed to a 3D reconstruction of
the particle representing the GIF:IL-2 assembly (Fig. 3c), which
conﬁrmed the shape incompatibilities with the crystal structure of
the GIF:GM-CSF complex and revealed structural features to
support a possible model representing the GIF:IL-2 complex
(Fig. 3d). The 3D EM envelope representing the GIF:IL-2
complex can be interpreted in terms of a GIF dimer occupying
the toe of the horseshoe mounted by two copies of IL-2 at the
poles of the GIF dimer (Fig. 3d). The resolution of the 3D EM
model did not allow us to discriminate the absolute orientation of
IL-2, although the features of the 3D EM model strongly suggest
that IL-2 is orientated with the longitude of its helical bundle
nearly perpendicular to the plane of the GIF dimer (Fig. 3d).
Indeed, similarly prepared and puriﬁed GIF:GM-CSF and
GIF:IL-2 complexes characterized by SAXS yielded scattering
data that despite the heterogeneous glycosylation levels of the
samples, support this interpretation and further show that the
two GIF–cytokine complexes have similar molecular weights
(Supplementary Fig. 3a–d; Supplementary Table 3).
To provide additional evidence for the molecular basis and
stoichiometry of the two structurally distinct GIF–cytokine
complexes we carried out a comparative analysis by SEC and
MALLS (Fig. 4a,b; Supplementary Fig. 4; Supplementary Table 4).
Table 1 | Crystallographic data collection and reﬁnement statistics.
GIF:oGM-CSF GIF:oGM-CSF, anisotropy corrected* oGM-CSF
Data collection statistics
Beamline P14 (PETRA III, Hamburg) P14 (PETRA III, Hamburg) P14 (PETRA III, Hamburg)
Space group C2 C2 P21
Cell dimensions
a, b, c (Å) 145.8, 105.7, 73.5 145.8, 105.7, 73.5 41.1, 77.0, 47.5
a, b, g () 90.0, 93.3, 90.0 90.0, 93.3, 90.0 90.0, 111.5, 90.0
Resolution (Å) 50.0–2.8 (3.0–2.8) 50.0–2.8 (3.0–2.8) 38.51–2.0 (2.1–2.0)
Unique reﬂections 25798 (4019) 21262 (1126) 18252 (2825)
Rmeas (%) 7.3 (112.1) 5.9 (53.5) 12.9 (73.2)
hI/s(I)i 20.4 (1.8) 23.2 (3.6) 8.2 (2.1)
CC(1/2) 99.9 (83.2)w 99.9 (83.2)w 98.7 (38.0)w
Completeness (%) 98.2 (95.7) 85.4 (25.1) 96.9 (94.0)
Multiplicity 6.9 (6.7) 5.9 (1.6) 3.3 (3.1)
Wilson B-factor (Å2) 86.4 58.3 25.7
Reﬁnement
Resolution (Å) 50.0–2.84 50.0–2.84 38.51–1.99
Rwork/Rfree 0.196/0.236
z 0.192/0.235 0.188/0.229
No. atoms 5,606 5,606 2,055
Protein 5,395 5,395 1,922
Glycan 184 184 —
Solvent 27 27 133
Average B factor (Å2) 62.1 62.1 34.5
Protein 61.0 61.0 34.1
Glycan 95.2 95.2 —
Solvent 39.6 39.6 39.8
R.m.s. deviations
Bonds (Å) 0.007 0.007 0.009
Angles () 0.925 0.925 1.068
Ramachandran favored (%) 96.3 96.3 98.3
Ramachandran outliers (%) 0 0 0
PDB access code 5D28z 5D28 5D22
Values in parentheses correspond to the highest-resolution shell.
CC(1/2)¼ percentage of correlation between intensities from random half-data sets80.
*Ellipsoidal truncation and anisotropic scaling of the data were performed using the Diffraction Anisotropy Server55.
wCorrelation signiﬁcant at the 0.1% level.
zStructure 5D28 (reﬁned against anisotropy corrected data) validated against full data range.
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Figure 1 | Crystal structure of the GIF:GM-CSF complex. (a) Dimeric GIF (pale green/dark green) is bound by two copies of ovine GM-CSF (blue/dark
blue). Disulﬁdes are shown as yellow spheres and N-linked glycans are depicted as sticks with transparent surface. The missing loop connecting b-strands
bJ and bK is represented as a dashed line. The two-fold non-crystallographic symmetry (NCS) axis present at the center of the GIF dimer interface is
indicated as a black oval. (b) Inset showing the GIF dimerization interface. Two GIF monomers are coloured in pale and dark green, disulﬁdes are shown as
yellow sticks and polar interactions are shown as dashed lines. (c) Inset of the GM-CSF (blue) binding epitope on GIF (green). Interacting residues are
shown as sticks, and hydrogen bonds/salt-bridges are shown as dashed lines. Interface residues for which mutation data is available are labeled in red
(see also Fig. 6; Supplementary Fig. 5; Supplementary Table 5). (c,d) Close-up view of interactions made by GIF residues R188 and K211, respectively.
(e) Close-up view of interactions made by GIF residues R188 and K211, respectively. (f) Inset displaying the WSXWS-like motif (WDPWV) present in the
F-G loop of GIF, which is involved in stabilizing the ﬁnal three C-terminal residues of b-strand K. (g) Solvent accessible surface potential representation of
the GIF:GM-CSF complex and individual subunits. The cytokine binding side of GIF is characterized by a basic surface potential complementary to the acidic
patch formed by helices aA and aD of GM-CSF. Visualizations were generated using the PDB2PQR74 and APBS75 software.
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Our analyses show that both the GIF:GM-CSF and the GIF:IL-2
complexes are chromatographically relatively monodisperse as
evidenced by the molecular weight proﬁles across each elution
peak, and that both complexes obey a 2:2 stoichiometry assuming
fully N-glycosylated proteins (Fig. 4a,b; Supplementary Table 4).
Addition of a large molar excess of puriﬁed cytokine to its
respective complex with GIF did not change the chromatographic
behaviour of the complex indicating that the puriﬁed
GIF–cytokine complexes were stable and fully occupied by
cytokines. Along these lines and to cross-validate the consistency
of the deduced 2:2 stoichiometry of the GIF:cytokine complexes,
we treated a given GIF–cytokine complex with a molar excess of
the second cytokine partner and analysed the resultant protein
mixtures by SEC-MALLS (Fig. 4c,d). Indeed, the SEC-MALLS
proﬁles showed that the 2:2 assemblies were conserved and that
the chromatographic proﬁles and ﬁts were consistent with the
exchange of one cytokine for the other (Fig. 4c,d). Therefore, we
conclude that GIF is able to adopt well deﬁned 2:2 stoichiometric
assemblies in the presence of GM-CSF and IL-2, despite its
aggregative propensity. In this regard, we note that we were only
able to observe chromatographically well-behaved GIF in the
presence of detergent (0.15% (w/v) CHAPS), albeit as an
unresolved mixture of dimers and tetramers (Supplementary
Fig. 4a)20. Finally, we note that glycan analyses of the two
complexes unmasked very complex N-glycan proﬁles suggestive
of high levels of sialylation, and by extrapolation expected
structural heterogeneity with respect to the glycan structures.
Thus, our structural analyses of GIF:GM-CSF and GIF:IL-2
complexes by several orthogonal approaches including X-ray
crystallography, EM, SAXS and SEC-MALLS illustrate that the
two GIF–cytokine complexes are structurally distinct based on
the ability of dimeric GIF to sequester two copies of each cytokine
to yield stable assemblies obeying 2:2 stoichiometry.
GIF binds GM-CSF and IL-2 via mutually exclusive epitopes.
Previous studies demonstrated that GIF inhibits the biological
activities of both ovine GM-CSF and ovine IL-2 in soft bone
marrow cell colony and T-cell proliferation assays, respectively20.
To characterize the interaction between GIF and its two
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Figure 2 | Sequence alignment of Orf GIF and members of the Poxviral Immune Evasion (PIE) family. Structural alignment performed by Expresso76 and
visualized by ESPript77. Used sequences include Orf virus (ORF) CKBP, vaccinia virus (VV) A41, ectromelia virus (EV) vCCI (EVM1), cowpox virus (CPV)
VCCI, rabbitpox virus (RPV) vCCI, cowpox virus (CPV) CPXV203 and ectromelia virus (EV) SECRET domain of CrmD. Conserved negatively and
positively charged residues are shown in red and blue respectively, conserved polar residues are shown in light blue and conserved hydrophobic residues
are shown in orange. Fully conserved residues are coloured black, with a yellow outline for cysteine. Conserved disulﬁde bonds are shown as connecting
dashed lines. Secondary structure elements in GIF are annotated above the corresponding sequences. Residues of GIF involved in interactions with GM-CSF
are shown as circles (red: interaction with helix aA, blue: interaction with helix aD of GM-CSF), whereas N-linked glycosylation sites in GIF are marked with
a green star.
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target cytokines kinetically and in terms of binding afﬁnity
we employed bio-layer interferometry (BLI) using biotinylated
GIF immobilized onto streptavidin-coated BLI sensors. Our
measurements reveal that GIF binds GM-CSF and IL-2 with high
afﬁnities yet with quite distinct kinetic binding proﬁles (Fig. 5a,b).
On one hand, binding of GM-CSF to GIF is characterized by
rather slow association kinetics and very slow dissociation
kinetics leading to a KD¼ 27 nM, whereas IL-2 binds to GIF
with B60-fold higher afﬁnity (KD¼ 0.47 nM) that can be
recapitulated by fast association kinetics and moderately slow
dissociation kinetics (Fig. 5a,b).
The unique capacity of GIF to bind tightly to two different
cytokines resulting in structurally distinct complexes prompted us
to explore the possible overlap between the GM-CSF and IL-2
binding epitopes. We thus carried out BLI experiments meant
to measure the possible binding of GM-CSF and IL-2 to
preassembled GIF:IL-2 and GIF:GM-CSF complexes, respectively,
at concentrations that would warrant the stability of the
preassembled complexes (Fig. 5c,d). We found that neither GM-
CSF nor IL-2 were able to bind additively to GIF already occupied
by the other cytokine, revealing that the cytokine binding sites on
GIF are mutually exclusive. In light of our structural analyses, it
would appear that the binding footprints of GM-CSF and IL-2 on
GIF might be overlapping to a certain degree (Figs 1 and 3).
To delineate the possible boundaries of the two distinct binding
epitopes utilized by GIF to sequester GM-CSF and IL-2, we
resorted to our high resolution snapshots of the GIF:GM-CSF
complex to design GIF variants carrying alanine mutations at
amino acids involved in the GIF:GM-CSF binding interface
(Figs 1c–e and 6a). Thus, given the overwhelmingly positive
electrostatic potential of the GIF-binding epitope (Fig. 1g),
we hypothesized that mutation of arginine, lysine and histidine
residues involved in more than one interaction with amino acids
on GM-CSF along the helix-A/D face of the helical bundle might
be appropriate candidate amino acids to mutate in GIF.
We therefore selected to mutate Arg45, Arg106, Arg188, Lys211
and His232, and were able to produce several single- and double-
mutation variants of GIF (Arg45Ala, Arg45Ala/Arg106Ala,
Arg188Ala, Arg106Ala/Arg188Ala, Lys211Ala, His232Ala) as
biotinylated recombinant proteins in HEK293T for binding studies
via BLI (Fig. 6; Supplementary Fig. 5a–l; Supplementary Table 5).
Our BLI data revealed that all mutations caused a B10 to
B120-fold decrease in the afﬁnity of GIF for GM-CSF, with
Lys211 on GIF constituting a true hotspot at the epicenter of the
binding interface (Fig. 6a; Supplementary Fig. 5e; Supplementary
Table 5). Interestingly, all mutations negatively affected the off-rate
of the interaction, which is quite remarkable given that all
mutations were alanine substitutions in the context of an
interaction footprint described by very pronounced electrostatics
(Fig. 1g). Such kinetic proﬁles lend support to the speciﬁcity of the
interactions concerned. Importantly, while all but one mutation
had no marked effect on the GIF:IL-2 interaction, Arg188Ala at the
far end of the GIF:GM-CSF interaction epitope bordering the
putative IL-2 binding site (Fig. 1c) elicited a 10-fold reduction in
the afﬁnity of the GIF:IL-2 interaction and a near 20-fold decrease
in the afﬁnity of the GIF:GM-CSF interaction by drastically
impacting the interaction off-rate (Fig. 6a; Supplementary Fig. 5i,f;
Supplementary Table 5). In light of our entire alanine-scanning
mutagenesis data set, this very fortuitous observation lends strong
support to the localization of the IL-2-binding footprint as
modeled immediately adjacent to, and quite possibly partly
overlapping with, the GM-CSF binding site (Fig. 6a). Indeed, such
mode of binding is corroborated well by the mutual exclusivity of
the two cytokine binding sites revealed by our binding studies
using wild-type GIF (Fig. 5c,d), because the presence of one
cytokine on GIF would sterically prevent binding of the other.
GIF interferes competitively with cytokine–receptor interfaces.
Given the observed high potency by which GIF speciﬁcally
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Figure 3 | Structural analysis of GIF:IL-2 and GIF:GM-CSF complexes by negative-stain EM. (a) Gallery of representative ab initio class averages of the
GIF:IL-2 complex and projections of the ﬁnal 3D reconstruction under similar orientations. (b) Ab initio class averages of the GIF:GM-CSF complex and
projections of the GIF:GM-CSF crystal structure under similar orientations. (c) Front and side views of a 3D reconstructed EM map for the GIF:IL-2 complex.
The 3D volume displays a characteristic horseshoe shape. (d) Fit of the crystal structure of dimeric GIF and a homology model of ovine IL-2 in the
corresponding EM map. The resulting model displays a horseshoe shaped complex formed by a GIF dimer bound by two copies of IL-2 (GIF dimer:
green/dark green, IL-2: orange/dark orange) and displays a two-fold symmetry axis centered at the GIF dimer interface, indicated as a black oval.
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neutralizes ovine GM-CSF and IL-2 (Fig. 5c,d) but not the human
counterparts (Fig. 5e,f) and in light of the GIF-mediated
abrogation of the bioactivity of the two cytokines in cellular
assays20, we sought to trace the structural basis for the
antagonistic properties of GIF. In the ﬁrst instance we
compared the binding mode of ovine GM-CSF to GIF with the
structure of human GM-CSF in complex with its cognate
receptors GMRa and bc (refs 32,33). The two GM-CSF
orthologues share 80% sequence identity and can be superposed
with an r.m.s.d. of 0.7 Å (backbone atoms). Our analyses show
that binding of GIF to GM-CSF drastically overlaps with both
cognate binding epitopes of GM-CSF to GMRa and bc (Fig. 6b).
Consequently, GIF can be classiﬁed at the outset as a competitive
decoy receptor for GM-CSF.
A closer look at the structural superimpositions reveals that
competitive antagonism by GIF goes well beyond a steric
exclusion mechanism. Remarkably, GIF engages several residues
in helices aA and aD of GM-CSF that would be involved in
binding to GMRa (Fig. 6b, sites 1 and 2). In particular we
highlight the deployment of Lys 211 by GIF to cap helix aD in
GM-CSF (Fig. 6b, site 2), which is exactly what the functionally
important Arg302 of GMRa does34,35 in the GMRa:GM-CSF
complex32. Furthermore, GIF employs a triad of residues
(Gln 108, Tyr 110 and Arg 45) to engage residue Asp112 in
GM-CSF, which constitutes a structural and functional hotspot
for interacting with GMRa (refs 34–36). Together, these analyses
show that GIF has adopted a mechanism of interface mimicry37
and illustrate how a viral protein bearing no sequence or
structural similarity to the cognate receptors of the target cytokine
has evolved convergently to sequester the target cytokine by
partially hijacking key principles and interactions underlying the
cognate cytokine–receptor complex. Indeed, such intricate
mimicry might present a daunting challenge to the host in
terms of developing an effective counter.
Regrettably, the lack of structural information at high
resolution for the binding of IL-2 to GIF limits us from making
a robust proposal for the possible structural mechanism under-
pinning the role of GIF as a viral decoy receptor to antagonize
IL-2-mediated signalling in the host. However, we note that the
likely near vertical orientation of the long axis of the helical
bundle of IL-2 with respect to the GIF dimer (Fig. 3d) in the
context of IL-2 in complex with IL-2Ra, IL-2Rb and gc (ref. 38),
would create severe steric hindrance for binding of either the
IL-2Rb or the gc receptor chains. Interestingly, it is well
established that binding of IL-2 to IL-2Ra primes IL-2 for
binding with a higher afﬁnity to IL-2Rb (refs 38,39). It is thus
tempting to consider whether GIF might play into the mechanism
of IL-2-mediated receptor activation by binding the activated
form of IL-2 with high afﬁnity to compete more effectively
against the cognate cytokine receptors.
Discussion
The Orf virus GIF protein provides a fascinating example of viral
protein evolution to enable evasion of the host immune response.
A decade and a half after the discovery of GIF as a viral protein
able to antagonize the bioactivity of both GM-CSF and IL-2
(ref. 20), two distinct cytokines pivotal to the host immune
response, we have presented here the structural and mechanistic
determinants underlying cytokine sequestration by GIF. GIF
neutralizes GM-CSF and IL-2 with high afﬁnity by engaging the
two cytokines on mutually exclusive binding epitopes on the
concave surface of its dimeric scaffold yielding two structurally
distinct complexes (Fig. 7). The structural and evolutionary
origins of GIF can be traced to a conserved beta-sandwich fold
that serves as the hallmark of the PIE domain superfamily40.
Although GIF does not bear any resemblance to the cognate
receptors of GM-CSF and IL-2 whatsoever, it targets hotspots and
mechanistic binding principles that are pivotal to the assembly of
productive complexes between GM-CSF and IL-2 and their
cognate receptors. In this regard, GIF joins a very sparsely
populated class of viral decoy cytokine receptors that are
structurally distinct from the cognate receptors, as was also
recently shown for BARF1 from the Epstein-Barr virus41, and the
Yaba-like disease virus 2L protein42.
The herein structural characterization of GIF now provides the
structural prototype for PIE viral proteins that target cytokines,
deﬁning a distinct functional branch in the phylogenetic tree of
the PIE superfamily (Fig. 8). Most structurally characterized
members of the PIE superfamily (vaccinia virus A41L (ref. 27),
ectromelia virus EVM1 (ref. 30), cowpox virus vCCI (ref. 28),
rabbitpox vCCI (ref. 29), Orf virus CKBP (ref. 31), and
the SECRET domain of the ectromelia virus CrmD43,44) are
functionally annotated as bona ﬁde chemokine binding proteins,
while a third functional branch is represented by a soluble
MHC Class 1-binding protein from the cowpox virus CPXV203
(ref. 45). A similar b-sandwich fold, albeit with a different
b-strand topology, is also found in the N-terminal domain of M3,
a chemokine binding protein secreted by murine g-herpesvirus
68 (ref. 46).
With such a wealth of structural data at hand we deemed it
opportune to trace the common and differentiating structural
features of the PIE superfamily (Fig. 9). The stunning versatility
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Figure 4 | SEC-MALLS analysis of GIF:GM-CSF and GIF:IL-2 complexes.
MALLS analysis of GIF:GM-CSF (a) and GIF:IL-2 (b) complexes puriﬁed after
co-expression of GIF and GM-CSF/IL-2 in HEK293T cells. GIF:GM-CSF (c)
and GIF:IL-2 (d) complexes re-puriﬁed after addition of a 10-fold excess of
puriﬁed IL-2 or GM-CSF respectively. For each, a graph is shown plotting the
differential refractive index and the derived molecular weight (grey) as a
function of the elution volume after SEC. The resulting mean MW and
corresponding standard deviation are presented at the top of each
chromatogram.
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Figure 5 | GIF binds GM-CSF and IL-2 with high afﬁnity and distinct binding kinetic proﬁles. (a,b) Kinetic proﬁles of GIF:GM-CSF and GIF:IL-2
interactions characterized by BLI. In each case, biotinylated GIF was coupled to the surface of streptavidin coated BLI sensors, followed by binding
measurements in different concentrations of GM-CSF/IL-2. Binding data was ﬁtted using a 1:1 interaction model. (c,d) BLI measurements of the binding
afﬁnity of GM-CSF and IL-2 after saturating GIF bound sensors with IL-2 or GM-CSF respectively. After saturation with GM-CSF/IL-2, binding to the other
cytokine is completely abolished (KD: NA¼ not applicable). (e,f) BLI measurements demonstrate that GIF does not bind to human orthologues of GM-CSF
and IL-2. Displayed KD, kd and ka values represent the average of three replicate experiments. Errors on the average KD, kd and ka values can be found in
Supplementary Table 5.
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of the common b-sandwich core becomes apparent when
comparing the targeting (CC and CXC chemokines, cytokines,
MHC class I molecules) as well as the binding epitope of ligands
binding the aforementioned proteins. Whereas Orf CKBP, A41
and vCCI all bind chemokines on the acidic surface formed by
b-sheet II, Orf GIF binds both GM-CSF and IL-2 through a basic
patch present on b-sheet I (Fig. 9a). Moreover, although the
surface charge distribution of b-sheets I and II is generally
conserved among PIE superfamily members, the ectromelia virus
SECRET domain displays reversed surface charge properties of
b-sheets I and II, and differs from other viral CKBPs since it
binds chemokines on the negatively charged surface of b-sheet I.
Conversely, b-sheet I is shielded away by two loops in A41 and
vCCI: one connecting b-strands bG and bH, and the second
present at the C-terminal end of both proteins. The bG–bH loop
serves a different role in Orf GIF, where it is involved in
GM-CSF binding through the functionally important Arg188
(Fig. 1c) as well as stabilizing the GIF dimer through binding to
the bG0–bH0 loop of an opposing GIF monomer. In Orf CKBP,
b-sheet I is occupied by the extra a-helix aC, which connects
b-strands bJ and bK. Cowpox virus CPXV203 on the other hand
uses the extra C-terminal helices aB and aC covering b-sheet I to
bind into a groove formed by subunits a2 and a3 of MHC1
(Fig. 9a). Helix aC is not present in Orf GIF, instead it is replaced
by an arginine- and proline-rich stretch of 15 amino acids
connecting bJ and bK. This loop region is predicted to be
unstructured and in fact we were not able to model it in the
electron density maps for the GIF:GM-CSF complex. Phyloge-
netic analysis suggests that the binding speciﬁcity of GIF towards
ovine GM-CSF and IL-2 most likely appeared after speciation of
the Orf virus16. It thus appears that the J-K loop diverged to an a-
helix in Orf CKBP and an unstructured loop in Orf GIF, which
allows the surface formed by b-sheet I to bind GM-CSF and IL-2
(Fig. 9b).
An intriguing aspect of the PIE superfamily b-sandwich fold
concerns its oligomerization capacity. A41, vCCI, CPXV203 and
the ectromelia virus SECRET domain form monomers in
solution, while Orf CKBP is an obligate dimer (Fig. 9a).
Interestingly, the SECRET domain present in the CrmB gene
from variola virus was also found to be a dimer47. Orf CKBP
dimerizes via b-sheet complementation involving its C-terminal
b-strand bK. A similar interface involving b-strand bK is found
in GIF dimers, where the binding between GIF monomers is
further strengthened by additional interactions mediated by the
G-H loop. By combining an oligomeric state with binding
multivalence on a single molecular platform that can engage the
target molecules with high afﬁnity into long-lived complexes, GIF
appears to recapitulate well the general strategy employed by viral
effector proteins and decoy receptors for inﬂicting a potent and
efﬁcient modulation of the host immune system within the
relatively short timeframes available to them41,48. Arguably, what
appears to set GIF apart from all other viral decoy receptors
characterized to date is not only its ability to target two different
cytokines but also the fact that it does so via structurally distinct
assemblies (Fig. 7). In the case of GM-CSF, the mechanistic
consequences of its sequestration by GIF can be traced to
interference with the cognate cytokine receptor binding interfaces
(Fig. 6b), which is likely the mechanism deployed for the
antagonism of IL-2 activity as well. Together, our work
contributes a novel example of the virtuosity and potency of
viral effector proteins and molecular decoys to achieve
immunomodulation of the host.
Methods
Protein production and puriﬁcation. Sequence optimized constructs containing
residues 18–144 of ovine GM-CSF (Uniprot code: P28773) and residues 21–155 of
ovine IL-2 (Uniprot code: P19114) were cloned in the pET-15b vector (Novagen)
and pHLsec vector49 encoding an N and C-terminal His6-tag respectively. Ovine
GM-CSF and IL-2 cloned in the pET-15b vector were expressed in BL21(DE3)
(Novagen) Escherichia coli cells and produced from inclusion bodies by rapid
dilution refolding (described in reference Verstraete et al.50), while the same
constructs cloned in the pHLsec vector were transiently expressed in mammalian
HEK293T cells49. Refolded oGM-CSF and oIL-2 were puriﬁed by IMAC using
prepacked 5ml Ni-NTA Superﬂow cartridges (QIAGEN). After binding, oGM-CSF
or oIL-2 were washed with 10 column volumes washing buffer (50mM NaH2PO4,
300mM NaCl, 15mM Imidazole pH 7.0) and eluted with 10 column volumes
elution buffer (50mM NaH2PO4, 300mM NaCl, 500mM Imidazole, pH 7.0).
After elution protein fractions were pooled, concentrated to a volume of 1ml
and injected onto a Prep-Grade Hiload 16/600 SD 75 size exclusion column
(GE Healthcare) equilibrated with HEPES-buffered saline buffer (HBS, 20mM
HEPES, pH 7.5, 150mM NaCl). oGM-CSF and oIL-2 expressed in HEK293T cells
were puriﬁed using the same puriﬁcation protocol as described above, but instead
of Ni-NTA cartridges, a Co2þ -packed TALON FF column (Clontech) was used
for IMAC.
A construct containing residues 1-265 of the Orf virus GM-CSF/IL-2 inhibition
factor (GIF, Uniprot code: Q9J5U5) was cloned into the pHLsec vector encoding a
C-terminal His6-tag49. His-tagged GIF was transiently expressed in HEK293T cells.
During transfection, sodium valproic acid (3.6mM) was added to the transfection
medium to boost expression levels. After 5 days of expression, medium was
harvested, supplemented with 0.15% (weight per volume) CHAPS and loaded onto
a Co2þ -packed TALON FF column (Clontech). During IMAC, the same buffers as
described above were used, supplemented with 0.15% (weight per volume) CHAPS.
Eluted GIF was pooled, concentrated and injected onto a Prep-Grade Hiload
16/600 SD 200 size exclusion column (GE healthcare) equilibrated with HBS
supplemented with 0.15% (weight per volume) CHAPS.
To generate GIF:oGM-CSF and GIF:oIL-2 complexes, GIF was either
co-expressed with oGM-CSF or oIL-2 in HEK293T cells by transient transfection49,
or puriﬁed after addition of an excess or refolded oGM-CSF or oIL-2 to the
HEK293T expression medium containing GIF. In each case, expression medium
was harvested after 5 days of co-expression and loaded onto a Co2þ -packed
TALON FF column (Clontech) or Ni2þ -packed complete column (Roche) for
oIL-2 and oGM-CSF, respectively. Subsequent IMAC and SEC puriﬁcation steps
were performed using the protocol as described for unliganded GIF, but without
adding CHAPS to puriﬁcation buffers.
Crystallization and data collection. All crystallization trials were set up using a
Mosquito robot (TTP LabTech) in a sitting drop vapour diffusion set-up with drop
volumes of 200 nl (100 nl protein solutionþ 100 nl reservoir solution). Refolded
oGM-CSF was concentrated to 5mgml 1 before initiating crystallization trials.
Large plate-like crystals were obtained at 293 K in a crystallization condition
containing 0.2M sodium acetate trihydrate, 0.1M TRIS hydrochloride pH 8.5 and
30% (weight per volume) PEG 4,000 (Hampton Crystal Screen 1, condition B10).
Crystals were scooped, transferred to mother liquor supplemented with 25%
ethylene glycol, and subsequently ﬂash-cooled in liquid nitrogen. Diffraction data
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GIF
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IL-2
GIF dimer
IL-2
GIF dimer
GM-CSF concentration
IL-2 concentration
Partial steric overlap
GM-CSF′ IL-2 GM-CSF′
GIF′ GM-CSF IL-2′
Figure 7 | Schematic mechanistic recapitulation of the two possible
GIF–cytokine complexes. GM-CSF (dark blue) and IL-2 (orange) have
partially overlapping binding sites on GIF (dark green). In the presence of an
excess of IL-2, the GIF:GM-CSF complex switches to a GIF:IL-2 complex,
and vice versa.
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were collected to 2.0 Å at the P14 microfocus beam line at PETRA III, Hamburg.
The obtained data set was processed using XDS51.
Puriﬁed complex between GIF produced in HEK293T cells and in vitro refolded
oGM-CSF produced in E. coli was concentrated to 6mgml 1. Small and highly
mosaic cube-like crystals were obtained at 293 K in a crystallization condition
containing 0.15M ammonium sulfate, 0.1 M MES pH 5.5 and 25% (weight per
volume) PEG4000 (Molecular Dimensions ProPlex screen, condition C10). After
optimization of this initial hit, new crystals with dimensions of 40 40 250mm
slowly grew over a period of 3 months in a condition containing 0.15M
ammonium sulfate, 0.1M MES pH 6 and 24% (weight per volume) PEG 4,000.
Before X-ray data collection, crystals were scooped, transferred to mother liquor
supplemented with 25% ethylene glycol, and ﬂash cooled in liquid nitrogen.
Diffraction data were collected to 2.84Å at the P14 microfocus beam line at
PETRA III, Hamburg, and subsequently processed using XDS51. An overview of all
data collection and reﬁnement statistics can be found in Table 1.
Structure determination and reﬁnement. Diffraction data for ovine GM-CSF
was processed in spacegroup P21 (a¼ 41.1 Å, b¼ 77.02 Å, c¼ 47.45 Å, b¼ 111.5).
Structure determination was performed by maximum-likelihood molecular
replacement (MR) in Phaser52 using the crystal structure of human GM-CSF
(PDB code 2GMF53) as a search model. The resulting single MR solution
was reﬁned in Phenix54 using positional and real-space reﬁnement with
non-crystallographic symmetry (NCS) restraints, individual anisotropic atomic
displacement parameter (ADP) reﬁnement and optimized X-ray/stereochemistry
and X-ray/ADP weights (Table 1; Supplementary Fig. 6).
The obtained data set for the GIF:oGM-CSF complex was processed in space
group C2 (a¼ 145.8 Å, b¼ 105.7 Å, c¼ 73.5 Å, b¼ 93.3). After manual inspection
of the collected data, severe anisotropy was observed. The data were ellipsoidally
truncated and anisotropically scaled on-line using the anisotropy server55,
which recommended resolution limits along the a*, b* and c* axes of 3.3 Å, 2.8 Å
and 2.7 Å, respectively. As no homologues of the Orf GIF protein are available, a
trimmed ensemble model was made with the program Ensembler of the Phenix
package by using two proteins distantly related to GIF, vaccinia virus A41L (ref. 27)
(PDB code¼ 2VGA, 19% sequence identity) and cowpox virus vCCI (ref. 28) (PDB
code¼ 1CQ3, 11% sequence identity). This trimmed ensemble and the reﬁned
structure of ovine GM-CSF, were used as search models for maximum-likelihood
MR in Phaser52. This led to an MR solution containing two trimmed ensembles
and two oGM-CSF molecules, whereby a GIF dimer is formed decorated by two
oGM-CSF molecules at equivalent positions on GIF. Initial reﬁnement cycles were
performed in Buster56 using NCS reﬁnement and anisotropic ADP reﬁnement with
TLS. After tracing of the main chain and most of the missing side-chains of GIF,
further reﬁnement cycles were carried out in Phenix using positional and real-space
reﬁnement with NCS restraints, individual anisotropic ADP reﬁnement combined
with TLS and optimized X-ray/stereochemistry weights (Table 1; Supplementary
Fig. 6).
Production of biotinylated proteins for kinetic studies. Residues 1–265 of Orf
GIF as well as six interface residue mutant GIF species (R45A, R45A/R106A,
R188A, R106A/R188A, K211A and H232A) were cloned in the pHLsec vector
containing a C-terminal AviTag49. The pHLsec-GIF-AviTag constructs were
transiently co-transfected in HEK293T cells with E. coli biotin ligase (BirA) cloned
in the pDisplay vector (pDisplayBirA-ER57). Before co-transfection, cell medium
was replaced by serum-free DMEM medium containing 100 mM of D-biotin. After
5 days of co-expression, expression medium was harvested and desalted using a
HiPrep 26/10 Desalting column (GE Healthcare) equilibrated with HBS to remove
excess D-biotin.
Bio-layer interferometry. All experiments were performed in 1 PBS (137mM
NaCl, 2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4, pH 7.4) supplemented
with 0.01% (w/v) bovine serum albumin and 0.002% Tween-20, using an Octet
RED96 instrument (ForteBio), operating at 298K. Streptavidin-coated biosensors
were functionalized with biotinylated GIF, quenched with a 10 mgml 1 biocytin
solution and then exposed to different concentrations of ligand (GM-CSF: 1–8 mM,
IL-2: 3.75–30 nM). To verify that no nonspeciﬁc binding was present during the
interaction assay, non-functionalized biosensors were used as a control by
measuring in parallel all ligand concentrations as well as running buffer. The
measurements presented in Fig. 5c were carried out based on sensor tips bound
with immobilized GIF saturated with 250 nM of oIL-2 and were used for
measurements against 20 mM oGMCSF. The measurements presented in Fig. 5d
were carried out based on sensor tips bound with immobilized GIF saturated with
20 mM oGMCSF and were used for measurements against 250 nM of oIL-2. All data
were ﬁtted with the Forte´Bio Data Analysis 7.1 software using a 1:1 interaction
model. All binding experiments were performed in triplicate. Displayed KD, kd and
ka values represent the averages of these triplicates.
Negative-stain electron microscopy and image analysis. GIF:IL-2 was applied
to the clean side of carbon on a carbon–mica interface and stained with 2% (weight
per volume) uranyl acetate. Images were recorded under low-dose conditions with
a JEOL 1,200 EX II microscope at 100 kV and at a nominal magniﬁcation of
40,000x. Negatives were digitized on a Zeiss scanner (Photoscan TD) to a pixel size
of 3.5 Å at the object scale (Supplementary Fig. 2a). A semi-automatic particle
selection with BOXER58 led to an extraction of a total of 26,910 GIF:IL-2 subframes
of 64 64 pixels. CTF correction and 2D reference-free classiﬁcation was
performed in RELION59 (Supplementary Fig. 2b). 2D class averages suggested the
presence of a two-fold symmetry axis. Three different sets of 30 to 40 best class
averages were extracted and used to calculate 12 ab initio 3D reconstructions of
GIF:IL-2 with VIPER applying a C2 symmetry60–62. All plausible solutions had a
similar horseshoe appearance with a well-deﬁned global core. Therefore, they were
aligned in 3D, averaged and ﬁltered to 50Å to create a low resolution GIF:IL-2 3D
model (Supplementary Fig. 2c). This model was further reﬁned in RELION using
3D auto-reﬁnement and 3D classiﬁcation procedures (Supplementary Fig. 2d). In
an attempt to better take the SAXS data into account, a SAXS model of GIF:IL2 was
ﬁltered to 50Å resolution and used as an initial model for another cycle of RELION
reﬁnement of the previously selected 24,324 GIF:IL-2 particles. This ﬁnal
reﬁnement resulted in 3D maps with a resolution of 17 Å according to the
FSC¼ 0.5 criterion (Supplementary Fig. 2e,f). The ﬁnal map was ﬁltered to 25Å
resolution.
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Figure 8 | Phylogenetic tree of members of the Poxviral Immune Evasion (PIE) superfamily with known structures. The phylogenetic tree, based on the
alignment presented in Supplementary Fig. 1, is generated by ClustalW2 (ref. 78) and visualized by Geneious 4.8.5 (ref. 79). The scale bar represents the
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GIF:GM-CSF was applied to the clear side of carbon on a carbon–mica interface
and stained with 2% (w/v) sodium silicotungstate, pH 7.5. Images were recorded
under low-dose conditions with a FEI Tecnai12 microscope operating at 120 kV and
at a nominal magniﬁcation of 49,000 using a Gatan Orius SC1,000 CCD camera.
The CTF for each micrograph was determined with CTFFIND3 (ref. 63). Using
projections of the crystal structure of GIF-GM-CSF ﬁltered to 18Å as templates,
particles were automatically selected from all the micrographs using the Fast
Projection Matching (FPM) algorithm64. The resulting data set was cleaned for bad
images. The ﬁnal 73,153 particles were ﬁltered to 25Å and two-dimensional (2D)
reference-free classiﬁcation was performed in RELION63 with no CTF correction.
Modeling of GIF and oIL-2 in the EM map. The crystal structure of dimeric GIF
and two copies of an oIL-2 homology model generated by MODELLER65 were
ﬁtted in the EM map of the GIF:oIL-2 complex using the autoﬁt procedure in
UCSF Chimera66.
Small-angle X-ray scattering. SEC-SAXS data were collected at the SWING
beamline at SOLEIL (France) using an integrated online HPLC set-up. Puriﬁed
samples of GIF:oGM-CSF and GIF:oIL-2 co-expressed in HEK293T cells were ﬁrst
concentrated to 10 and 8.8mgml 1 respectively before injection on a Superdex
Increase 10/300 GL size exclusion column (GE Healthcare) equilibrated with HBS
(pH 7.5) using an injection volume of 100 ml and a ﬂow rate of 0.5mlmin 1.
Measurements were performed at 293 K, within a momentum transfer range
of 0.01Å 1oso0.550 Å 1 (GIF:GM-CSF) and 0.01Å 1oso0.622 Å 1
(GIF:IL-2), where s¼ 4psin(y)/l and 2y is the scattering angle. Eighty nine buffer
frames with an exposure time of 1 s were averaged and subtracted from 10 1 s
frames (GIF:GM-CSF) or 16 1 s frames (GIF:IL-2) taken from the eluted protein
peaks. Scattering data were collected on an AVIEX PCCD170170 detector. Initial
data integration, averaging and subtraction were performed using the Foxtrot
software at SWING. The forward scattering (I0) and radius of gyration (Rg) were
determined by PRIMUS-QT67 using Guinier approximation68, and compared with
values for I0 and Rg calculated by SCÅTTER69. The Porod volume estimate (Vp)
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was evaluated using Autoporod70, the maximum particle dimension Dmax and
corresponding distance distribution function P(r) were evaluated using
SCÅTTER69. Molecular masses of GIF:oGM-CSF and GIF:oIL-2 complexes were
calculated using methods independent of calibration standards provided by the
SAXSMoW71 and SCÅTTER69 software. An overview of SAXS data collection,
structural parameters and MW determination can be found in Supplementary
Table 3.
Modeling of SAXS data. The crystal structure of the GIF:oGM-CSF complex and
the model of GIF:IL-2 based on the ﬁt in the EM map were used as an input for the
Allosmod-FoXS web server72 to model missing loops, N and C termini and
N-linked glycosylation. During each Allosmod-FoXS run, data up to a scattering
angle of 0.5 Å 1 was used. Fits of the resulting SAXS models of GIF:GM-CSF
and GIF:IL-2 complexes to the experimental SAXS data were calculated using the
FoXS software73.
Multi-angle laser light scattering. Puriﬁed oGM-CSF, oIL-2, GIF:oGM-CSF and
GIF:oIL-2 samples expressed in HEK293T cells were concentrated to 1–2mgml 1
and injected onto a Superdex Increase 10/300 GL size exclusion column
(GE Healthcare) equilibrated with HBS (pH 7.5), coupled to an online UV-detector
(Shimadzu), a mini DAWN TREOS (Wyatt) multi-angle laser light scattering
detector and an Optilab T-rEX refractometer (Wyatt) at 298 K. Following refractive
index (RI) increment values (dn/dc) were used for protein concentration and
molecular mass determination: ovine GM-CSF: 0.182ml g 1, ovine IL-2:
0.182ml g 1, GIF:oGM-CSF: 0.181ml g 1, GIF:oIL-2: 0.182ml g 1. Data analysis
was carried out using the ASTRA6.1 software. Theoretical and measured molecular
weights relevant to this study are summarized in Supplementary Table 4.
Data availability. Coordinates and structure factors for ovine GM-CSF and
the GIF:GM-CSF complex have been deposited in the Protein Data Bank (PDB)
with accession codes 5D22 and 5D28 respectively. EM maps obtained after
3D reconstruction of the GIF:IL-2 complex have been deposited in the Electron
microscopy Data Bank (EMDB) with accession code EMD-3230. Experimental
SAXS data, a SAXS model for the GIF:GM-CSF and GIF:IL-2 complexes after
loop and N-glycan modeling in Allosmod-FoXS, and the ﬁt with experimental
SAXS curves have been deposited in the Small-Angle Scattering Biological Data
Bank (SASBDB) with accession codes SASDA89 (GIF:GM-CSF) and SASDA99
(GIF:IL-2).
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